BCL2 and familial pancreatic carcinoma: Previous studies have demonstrated that the inhibition of PI3K sensitises pancreatic cancer to the apoptotic effect of chemotherapy; our studies provide data to define a signalling pathway that involves alterations in relative levels of BCL-2 family members.